Non-alcoholic fatty liver disease (NAFLD) is a terrible disease affecting many around the globe. The condition has a staggering prevalence of 30% worldwide. And that’s not all! Nearly 2 million people lose their battle against NAFLD each year globally. NAFLD is marked by the accumulation of fat and inflammation in the liver. The disease is …
More
Tag Archives: nicotinamide riboside human trials
Updating…